Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients.
Cornaby
A
A
Department of Surgery, Harvard Medical School, New England Deaconess Hospital, Boston, MA 02215.
Simpson
M
M
Vann Rice
R
R
Dempsey
R
R
Madras
P
P
Jenkins
R
R
Monaco
A
A
D003524:Cyclosporins / Q000633:toxicity*; D003937:Diagnosis, Differential; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood* / Q000652:urine*; D007674:Kidney Diseases / Q000175:diagnosis / Q000473:pathology; D016030:Kidney Transplantation; D016031:Liver Transplantation; D014556:Urine / Q000473:pathology
D003524:Cyclosporins; D007376:Interleukin-2